Clinical Application of cVEMPs and oVEMPs in Patients Affected by Ménière's Disease, Vestibular Neuritis and Benign Paroxysmal Positional Vertigo: A Systematic Review
Acta Otorhinolaryngologica Italica
Scarpa, A., Gioacchini, F. M., et al. (2019).
Acta Otorhinolaryngologica Italica, 39(5), 298-307.
This systematic review investigates the clinical applicability of vestibular evoked myogenic potentials (VEMPs) for identifying vestibular neuritis, Ménière's disease, and benign paroxysmal positional vertigo.
Not stated
Through April 2017
Published studies (not further specified)
26
For individuals with Ménière's disease (MD), ten studies found "both [cervical vestibular evoked myogenic potential] cVEMP and [ocular vestibular evoked myogenic potential] oVEMP showed better sensitivity and specificity compared with the caloric test, but a wide variety of described alterations in VEMPs recordings among the studies analysed were noted, with amplitude reduction representing the most frequent finding. For this reason, additional studies are needed to accurately identify specific anomalies in VEMPs recording associated with MD" (p. 305).
Six studies investigated the use of vestibular evoked myogenic potentials (VEMPs) for identifying vestibular neuritis in individuals. The authors concluded that "VEMPs ([cervical vestibular evoked myogenic potential] cVEMP together with [ocular vestibular evoked myogenic potential] oVEMP) may represent a useful tool in improving topographic diagnosis, offering key information about prognosis and therapy" (p. 305).
For individuals with benign paroxysmal positional vertigo (BPPV), thirteen studies found that vestibular evoked myogenic potentials (VEMPs) were often abnormal or missing in individuals with BPPV. The authors concluded that VEMPs may "be important in predicting pathological recurrences" (p. 305).